David A. Siegel Artivion, Inc. Transaction History
Two Sigma Advisers, LP
- $43.8 Billion
- Q2 2024
A detailed history of David A. Siegel (Two Sigma Advisers, LP) transactions in Artivion, Inc. stock. As of the latest transaction made, Two Sigma Advisers, LP holds 37,660 shares of AORT stock, worth $1.05 Million. This represents 0.0% of its overall portfolio holdings.
Number of Shares
37,660
Previous 56,400
33.23%
Holding current value
$1.05 Million
Previous $1.19 Million
19.11%
% of portfolio
0.0%
Previous 0.0%
Shares
17 transactions
Others Institutions Holding AORT
# of Institutions
164Shares Held
35.2MCall Options Held
21KPut Options Held
6.8K-
Black Rock Inc. New York, NY6.64MShares$185 Million0.0% of portfolio
-
Macquarie Group LTD Australia, C32.81MShares$78.4 Million0.08% of portfolio
-
Perceptive Advisors LLC New York, NY2.79MShares$77.9 Million2.07% of portfolio
-
Vanguard Group Inc Valley Forge, PA2.77MShares$77.3 Million0.0% of portfolio
-
Morgan Stanley New York, NY2.36MShares$65.8 Million0.0% of portfolio
About ARTIVION, INC.
- Ticker AORT
- Exchange NYSE
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 40,316,100
- Market Cap $1.12B
- Description
- Artivion Inc. manufactures, processes, and distributes medical devices and implantable human tissues worldwide. The company offers BioGlue, a polymer consisting of bovine blood protein and an agent for cross-linking proteins for cardiac, vascular, neurologic, and pulmonary procedures; cardiac preservation services; PhotoFix, a bovine pericardial...